People · Operator
Named in public records as an officer, director or promoter · active 2010–2026 · Software / Tech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PostProcess Technologies, Inc. | — | Software / Tech | Series B | $62.8M | $13.3M | 2022 |
| Pharminex, L.L.C. | — | Pharmaceuticals | Series A | $12.3M | $97.5M | 2010 |
Charles E Lannon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles E Lannon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Charles Lannon | 1 | 3 |
| John E Bellomo | 1 | 1 |
| Dan E. DiPofi | 1 | 1 |
| Jeff Mize | 1 | 1 |
| Sam E. Heleba | 1 | 1 |
| Matthew A. Ray | 1 | 1 |
| Usama A. Fayyad | 1 | 1 |
| James Kent | 1 | 1 |
| Daniel Hutchinson | 1 | 1 |
| Ulf Ivarrson | 1 | 1 |
| Jeffrey Mize | 1 | 1 |
| Jonathan Swiatkowski | 1 | 1 |
| Jonathan E Swiatkowski | 1 | 1 |
| John Bellomo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.